Adaptaquin

CAS No. 385786-48-1

Adaptaquin( —— )

Catalog No. M27498 CAS No. 385786-48-1

Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 Get Quote
10MG 72 Get Quote
25MG 147 Get Quote
50MG 237 Get Quote
100MG 372 Get Quote
200MG 531 Get Quote
500MG 849 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Adaptaquin
  • Note
    Research use only, not for human use.
  • Brief Description
    Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
  • Description
    Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    HIF/HIF Prolyl-hydroxylase
  • Recptor
    NEK6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    385786-48-1
  • Formula Weight
    377.82
  • Molecular Formula
    C21H16ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (264.68 mM)
  • SMILES
    Oc1cccnc1NC(c(cc1)ccc1Cl)c(ccc1cccnc11)c1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.De Donato M, et al. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6. Sci Rep. 2018;8(1):16047. Published 2018 Oct 30.
molnova catalog
related products
  • KC7F2

    A small molecule HIF-1α translation inhibitor with IC50 of 20 uM.

  • GN44028

    GN44028 is a hypoxia-inducible factor inhibitor of (HIF)-1 (IC50: 14 nM). GN44028 inhibits hypoxia-induced HIF-1α transcriptional activity.

  • Oltipraz

    Oltipraz (RP 35972, NSC 347901) is a cancer chemopreventive agent with inhibitory effect on angiogenesis and tumor growth.